Today on MedNet21, we're going to discuss Breast Cancer Treatment.
Following this presentation, learners should be able to identify the 3 main breast cancer subtypes, to recognize that receptor status determines the timing, duration and type of systemic therapy and to understand the basic indications for immunotherapy in breast cancer.
Dates and Times
End Date: 2/11/2025
ObjectivesAs a result of this educational activity, webcast participants will be able to: understand the basics of choosing systemic therapy options in the neoadjuvant/adjuvant and metastatic breast cancer
settings; and understand the approved indications for immunotherapy in triple negative breast cancer.
The Center for Continuing Medical Education (CCME) at The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians
The Center for Continuing Medical Education (CCME) at The Ohio State University designates this webcasts for a maximum of 1.00 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Maintenance of Certification
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.